Skip to content

A prospective, randomised controlled, multi-center trial comparing in-hospital treatment and early assisted discharge for exacerbations of Chronic Obstructive Pulmonary Disease (COPD).

A prospective, randomised controlled, multi-center trial comparing in-hospital treatment and early assisted discharge for exacerbations of Chronic Obstructive Pulmonary Disease (COPD). - Early assisted dischage for unstable COPD.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31318
Enrollment
235
Registered
2007-10-22
Start date
2007-12-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD - chronic brochitis and pulmonary emphysema

Interventions

The intervention group will be transferred home on day 4 of the admission. The control group remains hospitalized and receives the regulare care. The intervention group receives care of a respiratory

Sponsors

Zorgonderzoek Nederland (ZON)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: *>18 years an competent *moderate/severe exacerbation of COPD * written informed consent

Exclusion criteria

Exclusion criteria: * live-threated an clinically unstable condition * major uncontrolled co-morbidity * mental disability * active alcoholism and drug abuse * inability to understand the program * living outside the region of care of home care organisation * admission to the intensive care unit * indication for NIPPV * insufficient direct caregiver

Design outcomes

Primary

MeasureTime frame
Primary outcome is the score on the CCQ measured on day 7. This score represents the change in health status.

Secondary

MeasureTime frame
Secondary outcomes are: * number of treatment failures during the first week (patients that went on assissted discharge but their condition deteriorated requiring re-admission * health care utilization * costs * CCQ score at 3 months * 3-months re-admission rate * 3-months mortality rate * EQ-5D measured on day 7 and at 3 months * patient and caregiver satisfaction measured with a dutch translation of the COPD Project East Yorkshire Hospitals NHS Trust-Medical Chest Unit questionnaire.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)